NCF2 and metabolic dysfunction-associated steatotic liver disease: Moreover, some scholars have found that NCF2 may be a key molecule in patients with nonalcoholic fatty liver disease complicated with AF [34], and the expression of NCF2 is significantly upregulated in patients with AF [35].